Navigation Links
PharmSource CMO-CDMO Database Expands Coverage to Include Approved Pharmaceutical Products: Intelligence Resource for Analyzing Bio/Pharmaceutical Contract Manufacturing
Date:7/16/2013

Fairfax, VA (PRWEB) July 16, 2013

The newest CMO-CDMO database offering from PharmSource is an upgrade to the widely respected PharmSource ADVANTAGE online service, and is a ready resource for deep insight into bio/pharmaceutical contract manufacturing trends based on key data that - until now - were difficult to find in a single, highly dependable source. New features in PharmSources' STRATEGIC ADVANTAGE online service include research capabilities to:

  •     Identify approved pharmaceutical products by CMO/manufacturer, applicant name or by product characteristics (including dosage form, route of administration, injectable packaging type, API, and more).
  •     Conduct searches for approved products by proprietary or generic product names, sponsor type, FDA and EU approvals, etc.
  •     Research pharmaceutical Merger & Acquisition activity by transaction nature, buyer or seller.
  •     Identify contract manufacturers by ownership type, including: government agency, not-for profit, private – management owned, private – venture capital owned, public company, unit of public company, university, etc. Search results include data on contract revenue ranges, when available.
  •     Download all search results into Excel, including side-by-side comparisons of contractor capabilities. This new feature is extremely valuable, as it allows users to freely use PharmSource Strategic Advantage data as part of their vital internal tool-kit for understanding the industry and trends.

PharmSource STRATEGIC ADVANTAGE service adds important support for sourcing and procurement executives who regularly make outsourcing decisions and assess contract manufacturing partners. It gives them an excellent resource for conducting high-level strategic analyses, including the ability to quickly and easily compare contract manufacturers, both in the detailed manufacturing capabilities they offer, and in their product experience.

Contract manufacturers also find great value in PharmSource STRATEGIC ADVANTAGE as a primary strategic planning and benchmarking resource to assess comparative capabilities, performance and product history. Just as important, it provides critical insight into likely future resource needs, identifying which pharmaceutical dosage forms have the greatest likelihood of being outsourced, and other critically important trends that drive major business decisions. It also is a resource for making trusted referrals.

For a limited time, a complimentary test-drive of PharmSource STRATEGIC ADVANTAGE is being offered to qualified companies. For more information, contact PharmSource's Customer Service Department at +1-703-383-4903, ext. 101 / info[at]pharmsource[dot]com.

About PharmSource

PharmSource brings together buyers and sellers of contract services for the development of drugs, medical devices and diagnostics. A trusted provider of global market and business intelligence since 1996, PharmSource publishes reports and databases, and conducts surveys and analyses related to industry contract service activities and trends.

Contact:
+1-703-383-4903 Phone (USA, eastern time-zone)
info(at)pharmsource(dot)com
http://www.pharmsource.com

Read the full story at http://www.prweb.com/releases/2013/7/prweb10468238.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PharmSource Lead Sheet Adds Coverage of Medical Devices and Diagnostics
2. Waters and NIBRT Complete Work on Worlds First UPLC Glycan Database
3. HemoShear Partners with Expression Analysis (EA) to Develop a Human Drug-Induced Vascular Response Database
4. Elsevier Launches a New Product Literature Database Solution for Life Science Professionals
5. Conflict of Interest Management Tool Links with ProPublicas "Dollars for Docs" Database
6. ArteryHealth.org Launches as a Collective Database of Artery Health Research
7. WCCT Global (WCCT) & Verified Clinical Trials (VCT) Announce Medication Adherence Documentation Capabilities Have Been Added to the VCT Clinical Trials Database Registry
8. Verified Clinical Trials Will Exhibit at the Annual 2013 SCOPE Summit to Discuss the Professional Research Subject and the Clinical Trial Database Registry
9. ChemAxons Chemicalize.org Extends PubChem Database With Crowd-Sourced Chemistry From the Web
10. Verified Clinical Trials Exhibits at the Annual 2013 Partnerships In Clinical Trials to Discuss the Professional Research Subject and the Clinical Trial Database Registry
11. UV Flu Technologies Expands Its International Footprint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , Jan. 20, 2017 Bioptix, ... the "Company"), announced that on January 14, 2017 the ... under which the Company will terminate certain employees associated ... Diagnostics, Inc.  The Company commenced terminations on January 16, ... 30 days.  The Company may pay severance benefits in ...
(Date:1/21/2017)... 2017   Boston Biomedical , an industry leader ... cancer stemness pathways, today presented data from two clinical ... 2017 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers ... In a Phase Ib/II study of napabucasin ... cancer stemness pathways by targeting STAT3 – colorectal cancer ...
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... how current market conditions have influenced the most recent ... Regulus Therapeutics Inc. (NASDAQ: RGLS ), Abeona ... Inc. (NASDAQ: TBPH ), and Sage Therapeutics ... new research report by Grand View Research, global Biotech market size ...
(Date:1/20/2017)... January 20, 2017 http://www.Financialbuzz.com ... one of leading causes of death worldwide. There were ... number of cancer related deaths increased gradually over time, ... incidence rate of various cancers continues to drive demand ... report by Global Market Insights, Inc. cancer biological therapy ...
Breaking Biology Technology:
(Date:1/18/2017)...  In vitro diagnostic (IVD) companies were very active ... and Kalorama Information expects that trend to continue – ... Generally, uncertainty in reimbursement and healthcare reform in ... the acquisitions landscape. Instead of looking to buy technology, ... outside of their home country and also to increase ...
(Date:1/12/2017)... , Jan. 12, 2017  New research undertaken by ... of the future.  1,000 participants were simply asked which office ... which we may consider standard issue.  Insights on what ... were also gathered from futurists and industry leaders including ... James Canton .  Some of these ...
(Date:1/6/2017)... 6, 2017  Privately-held CalciMedica, Inc., announced that ... volunteers of a novel calcium release-activated calcium (CRAC) ... Acute pancreatitis, sudden painful inflammation ... but can be very serious.  In severe cases it ... extended hospital stays, time in the ICU and ...
Breaking Biology News(10 mins):